- Home
- GTIM vs BIVI Comparison
GTIM vs BIVI Comparison
Compare GTIM & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- BIVI
- Stock Information
- Founded
- GTIM 1987
- BIVI 2013
- Country
- GTIM United States
- BIVI United States
- Employees
- GTIM N/A
- BIVI N/A
- Industry
- GTIM Restaurants
- BIVI Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- BIVI Health Care
- Exchange
- GTIM Nasdaq
- BIVI Nasdaq
- Market Cap
- GTIM 17.1M
- BIVI 14.2M
- IPO Year
- GTIM 1990
- BIVI N/A
- Fundamental
- Price
- GTIM N/A
- BIVI $1.86
- Analyst Decision
- GTIM
- BIVI
- Analyst Count
- GTIM 0
- BIVI 0
- Target Price
- GTIM N/A
- BIVI N/A
- AVG Volume (30 Days)
- GTIM 15.0K
- BIVI 258.0K
- Earning Date
- GTIM 08-07-2025
- BIVI 11-12-2025
- Dividend Yield
- GTIM N/A
- BIVI N/A
- EPS Growth
- GTIM 17.03
- BIVI N/A
- EPS
- GTIM 0.12
- BIVI N/A
- Revenue
- GTIM $143,398,000.00
- BIVI N/A
- Revenue This Year
- GTIM N/A
- BIVI N/A
- Revenue Next Year
- GTIM N/A
- BIVI N/A
- P/E Ratio
- GTIM $13.91
- BIVI N/A
- Revenue Growth
- GTIM 1.78
- BIVI N/A
- 52 Week Low
- GTIM $1.34
- BIVI $1.42
- 52 Week High
- GTIM $3.00
- BIVI $75.00
- Technical
- Relative Strength Index (RSI)
- GTIM 51.45
- BIVI 39.65
- Support Level
- GTIM $1.58
- BIVI $1.81
- Resistance Level
- GTIM $1.68
- BIVI $2.04
- Average True Range (ATR)
- GTIM 0.05
- BIVI 0.12
- MACD
- GTIM 0.00
- BIVI 0.10
- Stochastic Oscillator
- GTIM 64.29
- BIVI 40.00
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.